BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20045424)

  • 1. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
    Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
    Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N; Mellott TJ; Berger-Sweeney JE
    Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome.
    Moretti P; Bouwknecht JA; Teague R; Paylor R; Zoghbi HY
    Hum Mol Genet; 2005 Jan; 14(2):205-20. PubMed ID: 15548546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rett syndrome: of girls and mice--lessons for regression in autism.
    Glaze DG
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
    Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
    Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
    Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice.
    Nag N; Moriuchi JM; Peitzman CG; Ward BC; Kolodny NH; Berger-Sweeney JE
    Behav Brain Res; 2009 Jan; 196(1):44-8. PubMed ID: 18687363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
    Ben-Zeev B; Aharoni R; Nissenkorn A; Arnon R
    Med Hypotheses; 2011 Feb; 76(2):190-3. PubMed ID: 20951500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.
    Pelka GJ; Watson CM; Radziewic T; Hayward M; Lahooti H; Christodoulou J; Tam PP
    Brain; 2006 Apr; 129(Pt 4):887-98. PubMed ID: 16467389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ups and downs of BDNF in Rett syndrome.
    Sun YE; Wu H
    Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
    Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
    Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
    Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
    Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal brain MRI study in a mouse model of Rett Syndrome and the effects of choline.
    Ward BC; Agarwal S; Wang K; Berger-Sweeney J; Kolodny NH
    Neurobiol Dis; 2008 Jul; 31(1):110-9. PubMed ID: 18571096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.
    Schaevitz LR; Nicolai R; Lopez CM; D'Iddio S; Iannoni E; Berger-Sweeney JE
    PLoS One; 2012; 7(12):e51586. PubMed ID: 23227269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
    Francke U
    Nat Clin Pract Neurol; 2006 Apr; 2(4):212-21. PubMed ID: 16932552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic hypofunction in MeCP2-308 mice: beneficial neurobehavioural effects of neonatal choline supplementation.
    Ricceri L; De Filippis B; Fuso A; Laviola G
    Behav Brain Res; 2011 Aug; 221(2):623-9. PubMed ID: 21457731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome.
    Belichenko NP; Belichenko PV; Li HH; Mobley WC; Francke U
    J Comp Neurol; 2008 May; 508(1):184-95. PubMed ID: 18306326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.
    Schaevitz LR; Gómez NB; Zhen DP; Berger-Sweeney JE
    Genes Brain Behav; 2013 Oct; 12(7):732-40. PubMed ID: 24283265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.